These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14657560)

  • 1. Replication-selective oncolytic adenoviruses.
    Halldén G; Thorne SH; Yang J; Kirn DH
    Methods Mol Med; 2004; 90():71-90. PubMed ID: 14657560
    [No Abstract]   [Full Text] [Related]  

  • 2. Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis.
    Nettelbeck DM
    Anticancer Drugs; 2003 Sep; 14(8):577-84. PubMed ID: 14501378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectively replicating adenoviruses for oncolytic therapy.
    Yoon TK; Shichinohe T; Laquerre S; Kasahara N
    Curr Cancer Drug Targets; 2001 Aug; 1(2):85-107. PubMed ID: 12188883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side effects of suicide gene therapy.
    van der Eb MM; de Leeuw B; van der Eb AJ; Hoeben RC
    Methods Mol Med; 2004; 90():479-90. PubMed ID: 14657580
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimisation of replication-selective oncolytic adenoviral mutants in combination with chemotherapeutics.
    Halldén G
    J BUON; 2009 Sep; 14 Suppl 1():S61-7. PubMed ID: 19785071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial).
    Lu M; Freytag SO; Stricker H; Kim JH; Barton K; Movsas B
    Contemp Clin Trials; 2011 May; 32(3):453-60. PubMed ID: 21300181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year follow-up of trial of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancer.
    Freytag SO; Stricker H; Peabody J; Pegg J; Paielli D; Movsas B; Barton KN; Brown SL; Lu M; Kim JH
    Mol Ther; 2007 Mar; 15(3):636-42. PubMed ID: 17228316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of suicide genes for cancer gene therapy: study of the different approaches.
    Vassaux G; Martin-Duque P
    Expert Opin Biol Ther; 2004 Apr; 4(4):519-30. PubMed ID: 15102601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vector vaccination and vector targeted chemotherapy in solid tumors.
    Akbulut H; Tang Y; Deisseroth A
    J BUON; 2009 Sep; 14 Suppl 1():S141-6. PubMed ID: 19785056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer.
    Bennett JJ; Malhotra S; Wong RJ; Delman K; Zager J; St-Louis M; Johnson P; Fong Y
    Ann Surg; 2001 Jun; 233(6):819-26. PubMed ID: 11371740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of replicating oncolytic adenoviruses in combination therapy for cancer.
    Chu RL; Post DE; Khuri FR; Van Meir EG
    Clin Cancer Res; 2004 Aug; 10(16):5299-312. PubMed ID: 15328165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach.
    Jiang G; Xin Y; Zheng JN; Liu YQ
    Int J Cancer; 2011 Jul; 129(2):263-74. PubMed ID: 21509783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic gene therapy combined with double suicide genes for human bile duct cancer in nude mouse models.
    Kojima Y; Honda K; Hamada H; Kobayashi N
    J Surg Res; 2009 Nov; 157(1):e63-70. PubMed ID: 19345377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer.
    Freytag SO; Barton KN; Brown SL; Narra V; Zhang Y; Tyson D; Nall C; Lu M; Ajlouni M; Movsas B; Kim JH
    Mol Ther; 2007 Sep; 15(9):1600-6. PubMed ID: 17551507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The current status of virotherapy for gastrointestinal cancer].
    Takahashi M; Niitsu Y
    Nihon Shokakibyo Gakkai Zasshi; 2004 Oct; 101(10):1078-86. PubMed ID: 15529780
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction to vectors for suicide gene therapy.
    Springer CJ
    Methods Mol Med; 2004; 90():29-45. PubMed ID: 14657557
    [No Abstract]   [Full Text] [Related]  

  • 18. Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases development.
    Lavilla-Alonso S; Bauer MM; Abo-Ramadan U; Ristimäki A; Halavaara J; Desmond RA; Wang D; Escutenaire S; Ahtiainen L; Saksela K; Tatlisumak T; Hemminki A; Pesonen S
    Cancer Gene Ther; 2012 Feb; 19(2):126-34. PubMed ID: 22095385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of oncolytic adenoviruses with chemotherapies: an overview and future directions.
    Bressy C; Benihoud K
    Biochem Pharmacol; 2014 Jul; 90(2):97-106. PubMed ID: 24832861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-driven approaches for in vitro combination therapy using ONYX-015 replicating oncolytic adenovirus.
    Zurakowski R; Wodarz D
    J Theor Biol; 2007 Mar; 245(1):1-8. PubMed ID: 17095020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.